C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2004
11/24/2004	EP1478643A1 5-heteroaryl substituted indoles
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478363A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1076055B1 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	EP0954374B1 Adsorbens and devices for the reduction of small organic compounds from blood products
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549815A Reductive cleavage of the exocyclic ester of UK-2A or its derivatives and products formed therefrom
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549716A 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
11/24/2004	CN1548428A Carboxylic acid derivatives having fused rings
11/24/2004	CN1176907C Substituted pyridine herbicides
11/24/2004	CN1176651C N-(3-benzofuryl) urea derivative
11/23/2004	US6822101 Reacting 1-(3-butynyl)-pyrrolidine or -piperidine with phenolic compound; cyclization; treating with boronic acid derivative; histamine-3 receptor ligands
11/23/2004	US6821990 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8 [4R-(3S-hydroxy-1-M ethyl) piperidinyl]-4H-1-benzopyran-4-one
11/23/2004	US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004	US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004	US6821977 Antidiabetic agents
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	US6821651 Red fluorescent material and organic electroluminescent device containing same
11/23/2004	CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/23/2004	CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004	WO2004099194A1 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
11/18/2004	WO2004099193A2 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof
11/18/2004	WO2004099192A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099191A2 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors
11/18/2004	WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099168A2 Substituted carboxylic acids
11/18/2004	WO2004099159A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	WO2004099157A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	WO2004099156A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004099146A1 Benzamide inhibitors of the p2x7 receptor
11/18/2004	WO2004099143A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004098528A2 Pyrazole-amine compounds useful as kinase inhibitors
11/18/2004	WO2004098518A2 Pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004098516A2 Cyclic derivatives as modulators of chemokine receptor activity
11/18/2004	WO2004078109A3 PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS
11/18/2004	WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/18/2004	WO2004043954A3 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
11/18/2004	US20040230072 Phosphodiesterase 4 inhibitors
11/18/2004	US20040230056 Process for synthesizing N-aryl piperazines with chiral N'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
11/18/2004	US20040229937 diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.
11/18/2004	US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
11/18/2004	US20040229931 1-Aryl-3-(indol-5-yl) prop-2-en-1-ones, compositions containing them and use
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229918 Phosphodiesterase 4 inhibitors
11/18/2004	US20040229915 Cysteine protease inhibitors
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/18/2004	US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	US20040229235 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
11/18/2004	US20040228854 Novel chemical substance having morphogenetic and growth-accelerating activities
11/18/2004	DE10335782A1 Chromenonderivate Chromenonderivate
11/18/2004	CA2524894A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
11/18/2004	CA2524397A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	CA2524324A1 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhibitors
11/18/2004	CA2524321A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/18/2004	CA2523743A1 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523714A1 Substituted carboxylic acids
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476448A2 Azabicyclic compounds for the treatment of disease
11/17/2004	EP1476441A1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides
11/17/2004	EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476164A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/17/2004	EP1476161A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0888338B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) 1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders

1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 694